Effects of lipoic acid and dihydrolipoic acid on total erythrocytic thiols under conditions of restricted glucose in vitro

Basic and Clinical Pharmacology and Toxicology

Volumn 100, Issue 2, 2007, Pages 139-144

  Coleman, Michael D ^a   Rimmer, Georgina S E ^a   Haenen, Guido R M M ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOATE; GLUCOSE; METHEMOGLOBIN; THIOCTIC ACID; THIOL DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; CELLS, CULTURED; DIABETES MELLITUS; ERYTHROCYTES; HUMANS; HYPOGLYCEMIA; METHEMOGLOBIN; SULFHYDRYL COMPOUNDS; THIOCTIC ACID;

EID: 33846427346     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.00025.x     Document Type: Article

References (27)

1. Soro-Paavonen A, Forbes JM. Novel therapeutics for diabetic micro- and macrovascular complications. Curr Med Chem 2006;13:1777-88.
2. Rahimi R, Nikfar S, Larijani BM, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365-73.
3. Coleman MD, Fernandez S, Khanderia L. A novel clinical monitoring method to evaluate a triple antioxidant combination (vitamins E, C and α-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation. Environ Toxicol Pharmacol 2003;14:33-42.
4. Carlson NG, Rose JW. Antioxidants in multiple sclerosis - Do they have a role in therapy? CNS Drugs 2006;20:433-41.
5. Chaudhary P, Marracci GH, Bourdette DN. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis. J Neuroimmunol 2006;175:87-96.
6. Oksala NKJ, Laaksonen DE, Lappalainen J et al. Heat shock protein 60 response to exercise in diabetes effects of alpha-lipoic acid supplementation. J Diabetes Complicat 2006;20:257-61.
7. Muthuswamy AD, Vedagiri K, Ganesan M, Chinnakannu P. Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: Role of L-carnitine and DL-alpha-lipoic acid. Clin Chim Acta 2006;368:84-92.
8. Bast A, Haenen GRMM. The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol 2002;11:251-8.
9. Bast A, Haenen GRMM. Lipoic acid. a multifunctional antioxidant. Biofactors 2003;17:207-13.
10. Constantinescu A, Picks U, Handelman GJ et al. Reduction and transport of lipoic acid by human erythrocytes. Biochem Pharmacol 1995;50:253-61.
11. Rezk BM, Haenen GRMM, van der Vijgh WJF, Bast A. Lipoic acid protects efficiently only against a specific form of peroxynitrite-induced damage. J Biol Chem 2004;279:9693-7.
12. Bast A, Haenen GRMM. Interplay between lipoic acid and glutathione in the protection against liposomal lipid peroxidation. Biochim Biophys Acta 1988;963:558-61.
13. Boots AW, Balk JM, Bast A, Haenen GRMM. The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity. Biochem Biophys Res Commun 2005;338:923-9.
14. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
15. Coleman MD. 'Commentary' The use of in vitro methaemoglobin generation to study antioxidant status in the diabetic erythrocyte. Biochem Pharmacol 2000;60:1409-16.
16. Coleman MD. Antioxidants: unlocking their potential. Environ Toxicol Pharmacol 2001;10:139-40.
17. Boyum A. Isolation of lymphocytes, granulocytes, and macrophages. Scand J Immunol 1976;5(Suppl 5):9-15.
18. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985;113:549-55.
19. Blakytny R, Harding JJ. Glycation (non-enzymatic glycosylation) inactivates glutathione reductase. Biochem J 1992;288:303-7.
20. Costagliola C. Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study. Clin Physiol Biochem 1990;8:204-10.
21. Bravi MC, Pietrangeli P, Laurenti O et al. Polyol pathway activation and glutathione redox status in non-insulin dependent diabetic patients. Metabolism 1997;46:1194-8.
22. Biewenga GP, Haenen GRMM, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997;29:315-31.
23. Teichert JJ, Kern HJ, Tritschler HJ, Ulrich H, Preiss H. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 1998;36:625-8.
24. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997;22:359-78.
25. Eyer P. Detoxication of N-oxygenated arylamines in erythrocytes: an overview. Xenobiotica 1988;18:1327-33.
26. Coleman MD, Williams C, Haenen GRMM. Effects of lipoic acid and dihydrolipoic acid on 4-aminophenol-mediated erythrocytic toxicity in vitro. Basic Clin Pharmacol Toxicol 2006;99:225-9.
27. Coleman MD, Coleman NA. Drug-iduced methaemoglobinaemia. Drug Saf 1996;14:394-405.